WO2007113650A2 - A novel and improved process fro the preparation of nateglinide and its polymorph form-h - Google Patents
A novel and improved process fro the preparation of nateglinide and its polymorph form-h Download PDFInfo
- Publication number
- WO2007113650A2 WO2007113650A2 PCT/IB2007/000869 IB2007000869W WO2007113650A2 WO 2007113650 A2 WO2007113650 A2 WO 2007113650A2 IB 2007000869 W IB2007000869 W IB 2007000869W WO 2007113650 A2 WO2007113650 A2 WO 2007113650A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nateglinide
- mixtures
- preparation
- cyclohexane
- trans
- Prior art date
Links
- OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 title claims abstract description 58
- 229960000698 nateglinide Drugs 0.000 title claims abstract description 47
- 238000000034 method Methods 0.000 title claims abstract description 23
- 230000008569 process Effects 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims description 23
- 239000000203 mixture Substances 0.000 claims abstract description 24
- 229930182832 D-phenylalanine Natural products 0.000 claims abstract description 19
- 238000006243 chemical reaction Methods 0.000 claims abstract description 18
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 claims abstract description 14
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims abstract description 12
- YXGDSBSUTMGHOL-UHFFFAOYSA-N 4-propan-2-ylcyclohexane-1-carbonyl chloride Chemical compound CC(C)C1CCC(C(Cl)=O)CC1 YXGDSBSUTMGHOL-UHFFFAOYSA-N 0.000 claims abstract description 11
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims abstract description 10
- YRQKWRUZZCBSIG-UHFFFAOYSA-N 4-propan-2-ylcyclohexane-1-carboxylic acid Chemical compound CC(C)C1CCC(C(O)=O)CC1 YRQKWRUZZCBSIG-UHFFFAOYSA-N 0.000 claims abstract description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 33
- 239000002904 solvent Substances 0.000 claims description 31
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 30
- -1 trimethylsilyl D-phenyl alanine Chemical compound 0.000 claims description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 8
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 claims description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 239000013078 crystal Substances 0.000 claims description 6
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 claims description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 4
- 150000001924 cycloalkanes Chemical class 0.000 claims description 4
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 claims description 4
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methylcyclopentane Chemical compound CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 claims description 4
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 4
- 238000006884 silylation reaction Methods 0.000 claims description 4
- 239000008096 xylene Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 claims description 2
- NOTFZGFABLVTIG-UHFFFAOYSA-N Cyclohexylethyl acetate Chemical compound CC(=O)OCCC1CCCCC1 NOTFZGFABLVTIG-UHFFFAOYSA-N 0.000 claims description 2
- NXFRBKOFHWLRLY-UHFFFAOYSA-N cyclopentane methylcyclopentane Chemical compound CC1CCCC1.C1CCCC1 NXFRBKOFHWLRLY-UHFFFAOYSA-N 0.000 claims description 2
- 150000001983 dialkylethers Chemical class 0.000 claims description 2
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims description 2
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 claims description 2
- 150000002825 nitriles Chemical class 0.000 claims 1
- 238000010791 quenching Methods 0.000 claims 1
- 230000000171 quenching effect Effects 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 17
- 238000010626 work up procedure Methods 0.000 abstract description 4
- 239000000047 product Substances 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- PAQZWJGSJMLPMG-UHFFFAOYSA-N 2,4,6-tripropyl-1,3,5,2$l^{5},4$l^{5},6$l^{5}-trioxatriphosphinane 2,4,6-trioxide Chemical compound CCCP1(=O)OP(=O)(CCC)OP(=O)(CCC)O1 PAQZWJGSJMLPMG-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- SWVMLNPDTIFDDY-SBSPUUFOSA-N methyl (2r)-2-amino-3-phenylpropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@H](N)CC1=CC=CC=C1 SWVMLNPDTIFDDY-SBSPUUFOSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- YXGDSBSUTMGHOL-KYZUINATSA-N CC(C)[C@H]1CC[C@H](C(Cl)=O)CC1 Chemical compound CC(C)[C@H]1CC[C@H](C(Cl)=O)CC1 YXGDSBSUTMGHOL-KYZUINATSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000012320 chlorinating reagent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- 235000008729 phenylalanine Nutrition 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 229940086542 triethylamine Drugs 0.000 description 2
- OELFLUMRDSZNSF-OFLPRAFFSA-N (2R)-2-[[oxo-(4-propan-2-ylcyclohexyl)methyl]amino]-3-phenylpropanoic acid Chemical compound C1CC(C(C)C)CCC1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-OFLPRAFFSA-N 0.000 description 1
- 0 *C(*)Cc1ccccc1 Chemical compound *C(*)Cc1ccccc1 0.000 description 1
- VQYXSRKVNPPTTM-UHFFFAOYSA-N 1-propan-2-ylcyclohexane-1-carboxylic acid Chemical compound CC(C)C1(C(O)=O)CCCCC1 VQYXSRKVNPPTTM-UHFFFAOYSA-N 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GWESVXSMPKAFAS-UHFFFAOYSA-N Isopropylcyclohexane Natural products CC(C)C1CCCCC1 GWESVXSMPKAFAS-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000002862 amidating effect Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229910052593 corundum Inorganic materials 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- LUSNEIVFFXOKHW-DAWZGUTISA-N methyl (2r)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoate Chemical compound C([C@H](C(=O)OC)NC(=O)C1CCC(CC1)C(C)C)C1=CC=CC=C1 LUSNEIVFFXOKHW-DAWZGUTISA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Definitions
- Nateglinide is a derivative of unnatural amino acid D-Phenyl alanine .It is taken immediately before meal and acts directly on pancreatic ⁇ -cells to restore the physiological early phase insulin secretion pattern, immediately after meals onset, which is lost in people with type-2 diabetes. It also enhances insulin secretion after meals during periods of elevated glucose levels (Hyperglycemia).
- Nateglinide is chemically known as N-[[fr «?w-4-(l-Methylethyl)cyclohexyl]carbonyl]-D- phenylalanine Or
- Nateglinide has CAS Registry Number [ 105816-04-4] and is represented by a compound of formula- 1
- JP 7017899 discloses preparation of Nateglinide from trans isopropyl cyclohexyl carboxylic acid in a single step using PCl 5 as per Scheme-3 :
- WO 2004/018408 discloses a synthesis of Nateglinide in which trans4-isopropyl cyclohexane carboxylic acid is converted to a mixed anhydride using alkyl chloroformate in ketonic solvent and reacting further with D-Phenylalanine in presence of alkali/base to give Nateglinide, these steps are depicted in Scheme-5:
- WO03/093222 describes the preparation of crystalline form "C" of N-(trans-4-isopropyl cyclohexylcarbonyl)- D- phenylalanine by reacting D-Phenylalanine methyl ester HCl with trans-4-isopropyl cyclohexane carboxylic acid in presence of propane phosphonic acid anhydride or LiOH-Al 2 O 3 in halogenated hydrocarbon solvents such as dichloromethane, dichloroethane at a temperature between -1O 0 C to 90 0 C followed by base hydrolysis.
- halogenated hydrocarbon solvents such as dichloromethane, dichloroethane at a temperature between -1O 0 C to 90 0 C followed by base hydrolysis.
- the product can be obtained by reacting trans-4 isopropyl cyclohexane carbonyl chloride with D-phenylalanine methyl ester HCl in halogenated hydrocarbon solvents such as dichloromethane, dichloroethane, in presence of base such as triethyl amine, pyridine at a temperature between -10 0 C to 90 0 C followed by base hydrolysis.
- halogenated hydrocarbon solvents such as dichloromethane, dichloroethane
- base such as triethyl amine, pyridine
- WO 02/32854A1 [equivalent to US 20040030182, EP1334963, CN1481356] describes a process wherein trans-4-isopropyl cyclohexyl carbonyl chloride is reacted with D- Phenylalanine in a mixed solvent of a ketone solvent and water in the presence of an alkali and then adjusting the temperature of the mixture to 58 0 C to 72 0 C and the concentration ketone solvent to more than 8 wt % and less than 22 wt % to conduct precipitation of Nateglinide crystals.
- WO 02/32853A1 [equivalent to US20040024219,EP 1334962, CN 1481355, CA 2425533] describes a process for the preparation of Nateglinide, which comprises the step of reacting trans-4-isopropyl cyclohexyl carbonyl chloride with D-Phenylalanine in a mixed solvent consisting of an organic solvent and water by keeping the different ratio of organic solvent and water, under conditions kept alkaline with potassium hydroxide.
- WO2004/005240A1 provides a process for the preparation of an intermediate in the synthesis of Nateglinide wherein trans-4- isopropylcyclohexane acid chloride is formed by reacting 4- isopropylcyclohexane carboxylic acid with thionyl chloride in the presence of an effective amount of an organic amide. It also provides processes for preparation of Nateglinide by acylation of a suitable salt of D-phenylalanine with trans- 4- isopropylcyclohexane acid chloride in both a single and a two-phase system, and in water free of a cosolvent.
- nateglinide is also discussed in US patents 5463116 and 5488150 which describe the preparation of form H type crystals of Nateglinide by treating B-type nateglinide crystals ( obtained by following Ex-3 of Japanese patent application laid open No. 63-54321) with a solvent at a temperature of atleast 10 0 C and forming crystals in the solvent at a temperatureof atleast 10 0 C.
- the main object of the. invention is to provide a commercially viable process for the preparation of nateglinide avoiding multistep extraction.
- Yet another object of the present invention is to provide an improved amidating method to give nateglinide comprising reaction of N,O-bis trimethyl silyl protected D- phenyl alanine with trans-4-isopropylcyclohexyl-l-carbonyl chloride in suitable solvent(s) followed by aqueous workup to give nateglinide.
- Yet another object of the present invention is to to provide an alternate process for preparation of nateglinide form-H.
- the present invention discloses a novel method of synthesis for the preparation of
- Phenylalanine in suitable solvent to give Nateglinide which is further purified in cyclohexane/ ethyl acetate to give form-H.
- the chlorinating agent used in this invention is oxalyl chloride.
- the solvent for this reaction is selected from:
- Aromatic hydrocarbons such as benzene, toluene, xylene or mixtures thereof, paraffins such as hexane , heptane, octane or mixtures thereof, cycloalkanes like cyclohexane, cyclopentane methyl cyclopentane, methyl cyclohexane or mixtures thereof, halogenated solvents such as dichloromethane, chloroform, 1,2-dichloroethane, carbon tetrachloride or mixtures thereof.
- the preferred solvent is dichloromethane.
- the temperature of the reaction varies from 25°- 150 0 C preferably at the reflux temperature of the solvent.
- D-Phenyl alanine is converted into N,O-bis trimethylsilyl D-Phenylalanine by using any of the available reagents like HMDS, BSU, BSA, or other silylating agents, the preferred reagent being HMDS.
- Solvents for carrying out silylation is selected from: Aromatic hydrocarbons like Benzene, toluene, xylene or mixtures thereof; Halogenated solvents like dichloromethane, chloroform, 1,2-dichloroethane, carbon tetrachloride or mixtures thereof;
- Ethers like THF, dioxane, 2-Methyl THF, dialkyl ether like diethyl ether,di propyl ether, dibutyl ether , or mixtures thereof;
- Paraffins like hexane , heptane, octane or or mixtures thereof;
- Cycloalkanes like cyclohexane, cyclopentane , methyl cyclopentane, methyl cyclohexane or mixtures thereof;
- Phenylalanine is carried out at 25 0 C to 150 0 C, preferably the reflux temperature of the solvent selected.
- Silylation of D-Phenylalanine is carried out in solvent (Acetonitrile) using silylating agent (HMDS) at about reflux temperature for about 3 hrs. The reaction mass is then cooled to -5°C to 0°C.
- reaction is further stirred at -4° to O 0 C for 3 hours and quenched with ice water, stirred for one hour, filtered , washed with water and dried to give crude nateglinide in
- Nateglinide prepared in step-2 is further processed using cyclohexane-Ethyl acetate to give Nateglinide form - H crystals.
- Nateglinide is stirred at reflux in cyclohexane and ethyl acetate is added till reaction mixture becomes clear. Then the solution is cooled to 45-48 0 C and stirred at same temperature for 16 to 18 hours. The reaction mass is cooled to 35 to 40 0 C , filtered and washed with cyclohexane and dried at 80-85 0 C to give Nateglinide form -H with an yield of 81 to 85 % ; melting point of 134-139 0 C and HPLC purity of >99.7 %
- the present invention relates to commercially viable process for the preparation of Nateglinide and its polymorph form-H.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Nateglinide is prepared by an improved process comprising reaction of trans-4-isopropyl cyclohexane carbonyl chloride with N,O-bis- trimethylsilyl protected D-phenyl alanine to give after aqueous workup, crude nateglinide which is converted to Nateglinide form- H using a mixture of cyclohexane / ethyl acetate. trans-4-isopropyl cyclohexane carbonyl chloride is prepared from trans-4- isopropyl cyclohexane carboxylic acid using oxalyl chloride.
Description
BACKGROUND OF THE INVENTION :
Nateglinide is a derivative of unnatural amino acid D-Phenyl alanine .It is taken immediately before meal and acts directly on pancreatic β-cells to restore the physiological early phase insulin secretion pattern, immediately after meals onset, which is lost in people with type-2 diabetes. It also enhances insulin secretion after meals during periods of elevated glucose levels (Hyperglycemia).
Nateglinide is chemically known as N-[[fr«?w-4-(l-Methylethyl)cyclohexyl]carbonyl]-D- phenylalanine Or
(-)-N-(fran.s'-4-isopropylcyclohexyl-l-carbonyl)-D-phenylalanme
Nateglinide has CAS Registry Number [ 105816-04-4] and is represented by a compound of formula- 1
Formula- 1
European patent 0196222 (1986) & J. Med. Chem (1989) vol. 32 page 1436 discloses synthesis of Nateglinide from trans 4-isopropyl cyclohexane carboxylic acid as shown in Scheme- 1 as follows:
] Nateglinide methyl ester
Nateglinide
US 4816484 and its subsequent reissue US RE 34878 discloses preparation of Nateglinide as per Scheme-2 as follows:
Scheme-2
JP 7017899 [Equivalent to JP4008794 ] discloses preparation of Nateglinide from trans isopropyl cyclohexyl carboxylic acid in a single step using PCl5 as per Scheme-3 :
Scheme-3
US 4816484, US RE 34878 and EP 196222 also describe other process for the preparation of Nateglinide in which trans-4-isopropycyclohexyl carboxylic acid is converted to its acid chloride and reacted with D-Phenylalanine in acetone using 10% sodium hydroxide to provide Nateglinide as described in scheme-4 : Scheme-4
Trans acid chloride
WO 2004/018408 discloses a synthesis of Nateglinide in which trans4-isopropyl cyclohexane carboxylic acid is converted to a mixed anhydride using alkyl chloroformate in ketonic solvent and reacting further with D-Phenylalanine in presence of alkali/base to give Nateglinide, these steps are depicted in Scheme-5:
Scheme-5
The drawbacks of this process are low overall yield [44 % ] , too many purifications, and use of mixtures of solvents making the process less attractive for commercial production.
WO03/093222 describes the preparation of crystalline form "C" of N-(trans-4-isopropyl cyclohexylcarbonyl)- D- phenylalanine by reacting D-Phenylalanine methyl ester HCl with trans-4-isopropyl cyclohexane carboxylic acid in presence of propane phosphonic acid anhydride or LiOH-Al2O3 in halogenated hydrocarbon solvents such as dichloromethane, dichloroethane at a temperature between -1O0C to 900C followed by base hydrolysis.
Alternatively, the product can be obtained by reacting trans-4 isopropyl cyclohexane carbonyl chloride with D-phenylalanine methyl ester HCl in halogenated hydrocarbon solvents such as dichloromethane, dichloroethane, in presence of base such as triethyl amine, pyridine at a temperature between -100C to 900C followed by base hydrolysis.
WO 02/32854A1 [equivalent to US 20040030182, EP1334963, CN1481356] describes a process wherein trans-4-isopropyl cyclohexyl carbonyl chloride is reacted with D- Phenylalanine in a mixed solvent of a ketone solvent and water in the presence of an alkali and then adjusting the temperature of the mixture to 580C to 720C and the concentration ketone solvent to more than 8 wt % and less than 22 wt % to conduct precipitation of Nateglinide crystals.
WO 02/32853A1 [equivalent to US20040024219,EP 1334962, CN 1481355, CA 2425533] describes a process for the preparation of Nateglinide, which comprises the
step of reacting trans-4-isopropyl cyclohexyl carbonyl chloride with D-Phenylalanine in a mixed solvent consisting of an organic solvent and water by keeping the different ratio of organic solvent and water, under conditions kept alkaline with potassium hydroxide. WO2004/005240A1 provides a process for the preparation of an intermediate in the synthesis of Nateglinide wherein trans-4- isopropylcyclohexane acid chloride is formed by reacting 4- isopropylcyclohexane carboxylic acid with thionyl chloride in the presence of an effective amount of an organic amide. It also provides processes for preparation of Nateglinide by acylation of a suitable salt of D-phenylalanine with trans- 4- isopropylcyclohexane acid chloride in both a single and a two-phase system, and in water free of a cosolvent.
US 2004/0077725 Al describes a process where in trans-4-isopropyl cyclohexyl carbonyl chloride is reacted with D-Phenylalanine methyl ester hydrochloride in presence of triethylamine in chloroform at room temperature for 10 hours to get a methyl ester of Nateglinide which on base hydrolysis in isopropyl alcohol yields Nateglinide.
In addition to the above references, nateglinide is also discussed in US patents 5463116 and 5488150 which describe the preparation of form H type crystals of Nateglinide by treating B-type nateglinide crystals ( obtained by following Ex-3 of Japanese patent application laid open No. 63-54321) with a solvent at a temperature of atleast 100C and forming crystals in the solvent at a temperatureof atleast 100C.
In general processes described in the prior art ,use hygroscopic, expensive reagents; involve multi-step extractive workup and involve the use of hazardous reagents like PC15 , DCC, propane phosphonic acid anhydride in ethyl acetate which are not preferred for large scale commercial operations.
SUMMARY OF THE INVENTION :
The main object of the. invention is to provide a commercially viable process for the preparation of nateglinide avoiding multistep extraction.
It is another object of the present invention to provide alternate chlorinating agents such as oxalyl chloride for converting trans-4-isopropyl cyclohexane carboxylic acid into trans-4-isopropyl cyclohexane carboxylic acid chloride.
Yet another object of the present invention is to to provide an improved amidating method to give nateglinide comprising reaction of N,O-bis trimethyl silyl protected D- phenyl alanine with trans-4-isopropylcyclohexyl-l-carbonyl chloride in suitable solvent(s) followed by aqueous workup to give nateglinide.
Yet another object of the present invention is to to provide an alternate process for preparation of nateglinide form-H.
DETAILED DESCRIPTION :
The present invention discloses a novel method of synthesis for the preparation of
Nateglinide from trans-4-isopropyl cyclohexane carboxylic acid, its conversion to an acid chloride by oxalyl chloride, and subsequent reaction with N,O-bis trimethylsilyl D-
Phenylalanine in suitable solvent to give Nateglinide , which is further purified in cyclohexane/ ethyl acetate to give form-H.
The present invention is described as per Scheme-6 as follows :
Scheme-6
trans-4-isopropyl cyclohexane trans-4-isopropyl cyclohexane carboxylic acid carboxylic acid chloride
D-Phenyl alanine
nateglinide form-H
Step-a
The chlorinating agent used in this invention is oxalyl chloride.
The solvent for this reaction is selected from:
Aromatic hydrocarbons such as benzene, toluene, xylene or mixtures thereof, paraffins such as hexane , heptane, octane or mixtures thereof, cycloalkanes like cyclohexane, cyclopentane methyl cyclopentane, methyl cyclohexane or mixtures thereof,
halogenated solvents such as dichloromethane, chloroform, 1,2-dichloroethane, carbon tetrachloride or mixtures thereof. The preferred solvent is dichloromethane. The temperature of the reaction varies from 25°- 1500C preferably at the reflux temperature of the solvent.
After the reaction, the solvent (methylene chloride) is distilled under vacuum to yield a product of 98 % purity Step-b
D-Phenyl alanine is converted into N,O-bis trimethylsilyl D-Phenylalanine by using any of the available reagents like HMDS, BSU, BSA, or other silylating agents, the preferred reagent being HMDS. Solvents for carrying out silylation is selected from: Aromatic hydrocarbons like Benzene, toluene, xylene or mixtures thereof; Halogenated solvents like dichloromethane, chloroform, 1,2-dichloroethane, carbon tetrachloride or mixtures thereof;
Ethers like THF, dioxane, 2-Methyl THF, dialkyl ether like diethyl ether,di propyl ether, dibutyl ether , or mixtures thereof;
Paraffins like hexane , heptane, octane or or mixtures thereof;
Cycloalkanes like cyclohexane, cyclopentane , methyl cyclopentane, methyl cyclohexane or mixtures thereof;
Nitrile group of solvents like acetonitrile, propionitrile , or mixtures thereof. Out of all the most preferred is by using HMDS in acetonitrile as solvent.
The silylation reaction is quantitative Moreover the deprotection of silylated compounds is also very facile and generates products, which are easily removed during workup procedure. The conversion of D-Phenylalanine to N,O-bis trimethylsilyl D-
Phenylalanine is carried out at 250C to 1500C, preferably the reflux temperature of the solvent selected.
Silylation of D-Phenylalanine is carried out in solvent (Acetonitrile) using silylating agent ( HMDS) at about reflux temperature for about 3 hrs. The reaction mass is then cooled to -5°C to 0°C.
Step-c
A solution of trans-4-isopropyl cyclohexane carboxylic acid chloride in solvent
(Acetonitrile) is added to a solution of N,O-bis trimethylsilyl D-Phenylalanine in solvent
( acetonitrile) over a period of 35 to 40 minutes maintaining temperature -4° to 00C.
The reaction is further stirred at -4° to O0C for 3 hours and quenched with ice water, stirred for one hour, filtered , washed with water and dried to give crude nateglinide in
88 to 90% yield with a melting point of 124-1280C and an HPLC purity of 98.5-99.5%
Step-d
Nateglinide prepared in step-2 is further processed using cyclohexane-Ethyl acetate to give Nateglinide form - H crystals.
The process for preparing nateglinide form H is as follows.
Nateglinide is stirred at reflux in cyclohexane and ethyl acetate is added till reaction mixture becomes clear. Then the solution is cooled to 45-480C and stirred at same temperature for 16 to 18 hours. The reaction mass is cooled to 35 to 400C , filtered and
washed with cyclohexane and dried at 80-850C to give Nateglinide form -H with an yield of 81 to 85 % ; melting point of 134-1390C and HPLC purity of >99.7 %
The present invention is illustrated by following examples which do not limit the scope of invention.
Example-1
Preparation of Trans-4-isopropyl cyclohexane carbonyl chloride
In 500 ml multinecked round bottom flask equipped with stirrer, thermometer and reflux condenser were charged 165 ml of methylene chloride and 65 gms of trans -4-isopropyl cyclohexane carboxylic acid and stirred at room temperature. To it was charged 55.3 gms of oxalyl chloride dropwise over a period of '20-25 minutes. The reaction mass was then heated to reflux and maintained at reflux temperature for 1.5 to 2 hours. Methylene chloride was distilled off to give product.
Yield=70 gms
Purity by GC= 98-99%
Example-2
Preparation of crude Nateglinide
In one litre capacity four necked flask equipped with oil bath for heating, stirrer, thermometer, condenser, and nitrogen gas passing arrangement , was charged 250 ml of acetonitrile followed by 50 gms of D-phenyl alanine, under nitrogen. To it 76 ml HMDS was added at room temperature under stirring. The reaction mass was then heated to reflux temperature and maintained for 3 hours. The reaction mass was then cooled under nitrogen flow to room temperature and then to -5 to O0C, followed by addition of 100ml of acetonitrile. To it a solution of 60 gms of trans-4-isopropyl cyclohexane carbonyl chloride in 100 ml of acetonitrile were added over a period of 35 to 40 minutes maintaining-4 to O0C under nitrogen. The reaction mixture was stirred at —5 to O0C for 3 hours. The reaction mixture was then quenched into -1.2 L of ice water, stirred for one hour, filtered and washed with water till the pH of the filtrate was 5-5.5. The material was dried in air and then in an oven at 70-750C for 6-8 hours till the moisture content becomes less than 1%.
Product Weight : 86-88gms [Crude Nateglinide]
Yield . : 88-90 %
Purity by HPLC -. 98.5-99.5 %
M.P. : 124-1280C
Example- 3
Preparation of Nateglinide form-H from crude Nateglinide
In 2 L capacity multi necked round bottom flask equipped with stirrer, oil bath for heating, condenser, thermometer and dropping funnel was charged 800 ml of cyclohexane followed by 80 gms of crude Nateglinide [product of Example-2] . The reaction mass was heated to reflux temperature. To it 160 ml of ethyl acetate were added dropwise at reflux temperature. Reaction mass was then a clear solution. The reaction mass was then cooled to 45-480C and maintained at 45-480C for 16-18 hours.
The solid was filtered at 35-400C, washed with 2x80 ml of cyclohexane , unloaded and dried in oven at 80-850C. This product was characterized as Nateglinide form-H.
Product Weight : 65-68 gms
Yield :81-85%
Purity by HPLC : >99.7 % Melting Point : 134-1390C
FIELD OF INVENTION :
The present invention relates to commercially viable process for the preparation of Nateglinide and its polymorph form-H.
Claims
We claim:
(I) A process for a preparation of nateglinide form H comprising steps: (a)Reacting trans-4-isopropyl cyclohexane carboxylic acid using oxalyl chloride in an organic solvent at its reflux temperature, to give trans-4-isopropyl cyclohexane carbonyl chloride,
(b) silylating D-phenyl alanine to N,O-bis trimethylsilyl D-phenyl alanine in a solvent at about the reflux temperature of solvent ,
(c) reacting a solution of trans-4-isopropyl cyclohexane carbonyl chloride, with a solution of N,O-bis trimethylsilyl D-phenyl alanine followed by quenching in water to obtain crude nateglinide,
(d) crystallizing the crude nateglinide from a mixture of cyclohexane-ethyl acetate to give nateglinide form-H crystals.
(2) A process for preparation of nateglinide form H, as claimed in claim- 1 wherein the solvent used in step (a) is selected from aromatic hydrocarbons such as benzene, toluene, xylene , or mixtures thereof; paraffins such as hexane , heptane, octane, or mixtures thereof; cycloalkanes such as cyclohexane, cyclopentane methyl cyclopentane, methyl cyclohexane or mixtures thereof; halogenated solvents such as dichloromethane, chloroform, 1,2-dichloroethane, carbon tetrachloride or mixtures thereof.
(3) A process for preparation of nateglinide form H, as claimed in claim-2, wherein the solvent is dichloromethane.
(4) A process for preparation of nateglinide form H, as claimed in claim- 1 wherein the silylation in step (b) is carried out using a silylating agent such as HMDS, BSU, BSA.
(5) A process for preparation of nateglinide foπn H, as claimed in claim- 1 wherein the solvent used in step (b) is selected from aromatic hydrocarbons such as benzene, toluene, xylene , or mixtures thereof; halogenated solvents such as dichloromethane, chloroform, 1,2-dichloroethane, carbon tetrachloride , or mixtures thereof ; ethers such as THF, dioxane, 2-Methyl THF, dialkyl ether such as diethyl ether, dipropyl ether, dibutyl ether , or mixtures thereof; paraffins such as hexane , heptane, octane or mixtures thereof; cycloalkanes such as cyclohexane, cyclopentane , methyl cyclopentane, methyl cyclohexane or mixtures thereof; nitriles such as acetonitrile, propionitrile , or mixtures thereof.
(6) A process for preparation of nateglinide form H, as claimed in claim- 5, wherein the solvent is acetonitrile.
(7) A process for preparation of nateglinide form H, as claimed in claim- 1 wherein the reaction of N,O-bis trimethylsilyl D-Phenylalanine with trans-4-isopropyl cyclohexane carbonyl chloride in step ( c ) is carried out at -10 to 200C, preferably at -4 toO°C .
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN532MU2006 | 2006-04-05 | ||
IN532/MUM/2006 | 2006-04-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007113650A2 true WO2007113650A2 (en) | 2007-10-11 |
WO2007113650A3 WO2007113650A3 (en) | 2009-04-16 |
Family
ID=38564027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/000869 WO2007113650A2 (en) | 2006-04-05 | 2007-04-04 | A novel and improved process fro the preparation of nateglinide and its polymorph form-h |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007113650A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7767847B2 (en) | 2003-07-10 | 2010-08-03 | Richter Gedeon Vegyeszeti Gyar Rt. | Process for the preparation of chirally pure N-(trans-4-is) |
CN109369443A (en) * | 2018-11-05 | 2019-02-22 | 扬子江药业集团江苏海慈生物药业有限公司 | A kind of preparation method of new Nateglinide H crystal form |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816484A (en) * | 1985-03-27 | 1989-03-28 | Ajinomoto Co., Inc. | Hypoglycemic agent |
US20040030182A1 (en) * | 2000-10-18 | 2004-02-12 | Ajinomoto Co. Inc. | Methods for producing nateglinide crystals |
-
2007
- 2007-04-04 WO PCT/IB2007/000869 patent/WO2007113650A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816484A (en) * | 1985-03-27 | 1989-03-28 | Ajinomoto Co., Inc. | Hypoglycemic agent |
US20040030182A1 (en) * | 2000-10-18 | 2004-02-12 | Ajinomoto Co. Inc. | Methods for producing nateglinide crystals |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7767847B2 (en) | 2003-07-10 | 2010-08-03 | Richter Gedeon Vegyeszeti Gyar Rt. | Process for the preparation of chirally pure N-(trans-4-is) |
CN109369443A (en) * | 2018-11-05 | 2019-02-22 | 扬子江药业集团江苏海慈生物药业有限公司 | A kind of preparation method of new Nateglinide H crystal form |
Also Published As
Publication number | Publication date |
---|---|
WO2007113650A3 (en) | 2009-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7989653B2 (en) | Exo- and diastereo-selective syntheses of himbacine analogs | |
WO2007113650A2 (en) | A novel and improved process fro the preparation of nateglinide and its polymorph form-h | |
US20110039937A1 (en) | Novel process for the preparation of vorinostat | |
JP2022525662A (en) | Method for preparing high-purity allopregnanolone and its intermediates | |
US20130123522A1 (en) | Process for preparation of lacosamide and some n-benzyl-propanamide intermediate derivatives | |
US9346744B2 (en) | Process for the preparation of lacosamide and its novel intermediate | |
JP3759411B2 (en) | 4-Cyano-3-hydroxybutanoylhydrazines, derivatives thereof and method for producing the same | |
CN112272665A (en) | Process for preparing sitagliptin | |
JP4165198B2 (en) | Sphingomyelin analogs and methods for their production | |
JP4929717B2 (en) | Process for producing N, N'-dialkoxy-N, N'-dialkyloxamide | |
JP2590220B2 (en) | Method for producing α-aminoacetonitrile mineral salts | |
JP3957780B2 (en) | Process for producing alkylcarboxylic acid 4-hydroxyanilide | |
AU5727098A (en) | Preparation of acylated alpha-amino carboxylic acid amides | |
JP4384315B2 (en) | Method for producing 3-nitro-2- (Nt-butoxycarbonyl) aminobenzoic acid esters and production intermediates thereof | |
JP4013772B2 (en) | 2-Hydroxyimino-3-oxopropionitrile and process for producing the same | |
US20070037971A1 (en) | Process for desilylation of carbapenem intermediates | |
JP3605855B2 (en) | Method for producing α-dehydroamino acid ester | |
JP2001151745A (en) | METHOD FOR PRODUCING 3-NITRO-2-(N-t-BUTOXYCARBONYL)- AMINOBENZOATES AND INTERMEDIATE FOR PRODUCING THE SAME ESTERS | |
US20210122777A1 (en) | A process for preparing ketolide compounds | |
US20230174569A1 (en) | PROCESS PER PREPARING (3a,5a)-20-OXOPREGNAN-3-YL GLYCYL-L-VALINATE HYDROCHLORIDE | |
US7094928B2 (en) | Process for the synthesis of (±) 2-Amino-N-[2,(2,5-dimethoxy phenyl)-2-hydroxyethyl] acetamide monohydrochloride | |
KR100667678B1 (en) | Process for preparing phenyl alanine derivatives | |
JP2004067577A (en) | Method for producing thienyl ketoester | |
JP2002308840A (en) | Method for steroselectively reducing 3-aryl-3- iminopropionic ester | |
JP2004075643A (en) | Method for producing coumarin compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07734190 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07734190 Country of ref document: EP Kind code of ref document: A2 |